BACKGROUND: Decreased endothelial nitric oxide (NO) synthase (eNOS) activity and NO production are critical contributors to the endothelial dysfunction and vascular complications observed in many diseases, including diabetes mellitus. Extracellular nucleotides activate eNOS and increase NO generation; however, the mechanism of this observation is not fully clarified. METHODS AND RESULTS: To elucidate the signaling pathway(s) leading to nucleotide-mediated eNOS phosphorylation at Ser-1177, human umbilical vein endothelial cells were treated with several nucleotides, including ATP, UTP, and ADP, in the presence or absence of selective inhibitors. These experiments identified P2Y1, P2Y2, and possibly P2Y4 as the purinergic receptors involved in eNOS phosphorylation and demonstrated that this process was adenosine independent. Nucleotide-induced eNOS phosphorylation and activity were inhibited by BAPTA-AM (an intracellular free calcium chelator), rottlerin (a protein kinase Cdelta inhibitor), and protein kinase Cdelta siRNA. In contrast, blockade of AMP-activated protein kinase, calcium/calmodulin-dependent kinase II, calcium/calmodulin-dependent kinase kinase, serine/threonine protein kinase B, protein kinase A, extracellular signal-regulated kinase 1/2, and p38 mitogen-activated protein kinase did not affect nucleotide-mediated eNOS phosphorylation. CONCLUSIONS: The present study indicates that extracellular nucleotide-mediated eNOS phosphorylation is calcium and protein kinase Cdelta dependent. This newly identified signaling pathway opens new therapeutic avenues for the treatment of endothelial dysfunction.
BACKGROUND: Decreased endothelial nitric oxide (NO) synthase (eNOS) activity and NO production are critical contributors to the endothelial dysfunction and vascular complications observed in many diseases, including diabetes mellitus. Extracellular nucleotides activate eNOS and increase NO generation; however, the mechanism of this observation is not fully clarified. METHODS AND RESULTS: To elucidate the signaling pathway(s) leading to nucleotide-mediated eNOS phosphorylation at Ser-1177, human umbilical vein endothelial cells were treated with several nucleotides, including ATP, UTP, and ADP, in the presence or absence of selective inhibitors. These experiments identified P2Y1, P2Y2, and possibly P2Y4 as the purinergic receptors involved in eNOS phosphorylation and demonstrated that this process was adenosine independent. Nucleotide-induced eNOS phosphorylation and activity were inhibited by BAPTA-AM (an intracellular free calcium chelator), rottlerin (a protein kinase Cdelta inhibitor), and protein kinase Cdelta siRNA. In contrast, blockade of AMP-activated protein kinase, calcium/calmodulin-dependent kinase II, calcium/calmodulin-dependent kinase kinase, serine/threonine protein kinase B, protein kinase A, extracellular signal-regulated kinase 1/2, and p38 mitogen-activated protein kinase did not affect nucleotide-mediated eNOS phosphorylation. CONCLUSIONS: The present study indicates that extracellular nucleotide-mediated eNOS phosphorylation is calcium and protein kinase Cdelta dependent. This newly identified signaling pathway opens new therapeutic avenues for the treatment of endothelial dysfunction.
Authors: Elzbieta Kaczmarek; Laurie Erb; Katarzyna Koziak; Robert Jarzyna; Marcia R Wink; Olaf Guckelberger; J Krzysztof Blusztajn; Vickery Trinkaus-Randall; Gary A Weisman; Simon C Robson Journal: Thromb Haemost Date: 2005-04 Impact factor: 5.249
Authors: Lingwei Wang; Lena Karlsson; Sara Moses; Anna Hultgårdh-Nilsson; Maria Andersson; Catharina Borna; Tomas Gudbjartsson; Sverker Jern; David Erlinge Journal: J Cardiovasc Pharmacol Date: 2002-12 Impact factor: 3.105
Authors: Leszek Kalinowski; Lawrence W Dobrucki; Miroslawa Szczepanska-Konkel; Maciej Jankowski; Ludmila Martyniec; Stefan Angielski; Tadeusz Malinski Journal: Circulation Date: 2003-05-12 Impact factor: 29.690
Authors: Michelle I Lin; David Fulton; Roger Babbitt; Ingrid Fleming; Rudi Busse; Kirkwood A Pritchard; William C Sessa Journal: J Biol Chem Date: 2003-09-02 Impact factor: 5.157
Authors: Maria D Dănilă; Andreea Privistirescu; Oana M Duicu; Corina D Rațiu; Denis Angoulvant; Danina M Muntean; Adrian Sturza Journal: Mol Cell Biochem Date: 2017-02-17 Impact factor: 3.396
Authors: Luke B Potts; Yi Ren; Guangrong Lu; Enoch Kuo; Ellen Ngo; Lih Kuo; Travis W Hein Journal: Invest Ophthalmol Vis Sci Date: 2012-05-17 Impact factor: 4.799